An Objective Double-blind Evaluation of Bupropion and Citalopram in an Individual With Friedreich Ataxia

• Status: Completed
• Trial end date: 2013-03-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to document the clinical effects of bupropion and citalopram in a single subject with Friedreich Ataxia.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Colorado, Denver
• Treatments: Bupropion; Citalopram; Dexetimide

Criteria

Inclusion Criteria:

• Friedreich Ataxia

Exclusion Criteria:

• Unable to provide Informed Consent